glp 1 drugs for parkinson's disease Are GLP-1 diabetes like Ozempic coming disease? — Parkinson Secrets The Emerging Role of GLP-1

Type 2 diabetes mellitus (T2DM) is a widespread metabolic disorder characterized by insulin resistance and pancreatic -cell dysfunction, posing a substantial global health challenge

2021 Wegovy (semaglutide) A pivotal moment in obesity treatment, demonstrating unprecedented weight-loss outcomes and changing both clinical practice and public perception

Here's the secret: This med is so good, it's skipping the FDA?

Various GLP-1RAs have been demonstrated to have significant benefits in in vitro and in vivo models of neurodegenerative diseases through modulating a variety of pathogenic mechanisms, including neuroinflammation, autophagy, mitochondrial dysfunction, and the abnormal phosphorylation of pathognomonic proteins